SMS Pharmaceuticals Limited has informed the Exchange about Shareholders meeting
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Pharmaceuticals held its 37th Annual General Meeting on 29th September 2025 via video conference, chaired by Chairman and Managing Director Mr. Ramesh Babu Potluri. Seven business items were transacted, including adoption of audited standalone and consolidated financial statements for FY ended 31st March 2025, declaration of a dividend on equity shares for FY2024-25, and re-appointment of Mr. Trilok Potluri as a director retiring by rotation. Shareholders also approved a material related party transaction with VKT Pharma Private Limited, remuneration for cost auditors for FY2025-26, appointment of secretarial auditors, and the re-appointment of Mr. Vamsi Krishna Potluri as Executive Director with a fixed remuneration via a special resolution. Remote e-voting was conducted from 25th to 28th September 2025 via CDSL, with consolidated voting results to be announced within two working days of the meeting, which concluded at around 12:05 PM.
Routine AGM disclosure with no negative surprises; confirms dividend for FY25 and continuity of key directors, including Executive Director Vamsi Krishna Potluri. Shareholders should await the scrutinizer's report for the final voting outcome on resolutions, especially the related party transaction with VKT Pharma.